• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SPECTRANETICS SPECTRANETICS LEAD LOCKING DEVICE; LLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SPECTRANETICS SPECTRANETICS LEAD LOCKING DEVICE; LLD Back to Search Results
Model Number 518-019
Device Problem Device Inoperable (1663)
Patient Problems Scar Tissue (2060); Pericardial Effusion (3271)
Event Date 12/19/2016
Event Type  Injury  
Event Description
Lead management case to extract 2 cardiac leads.The target lead was a non-functioning mdt 4024 (implanted in 1998) in the rv.The lead was prepped and an lld #2 was inserted.A 14f glidelight sheath was then utilized on the rv lead but progress stalled due to lead on lead binding in the svc.The ra lead (mdt 4524) was then prepped and another lld #2 was placed in the lead.A 14f glidelight was then utilized a second time however progress still stalled in the svc.A 13f tightrail was then selected and loaded onto the rv lead eventually freeing the lead from the area of the svc.Use of the tightrail led to successful removal of the rv lead.At time of lead tip removal, significant scar tissue was noted on the tip of the rv lead.The patient¿s vitals remained stable so the physician continued on to extract the ra lead.Upon entering the subclavian with the tightrail the lead pulled back into the subclavian.Upon removal of the ra lead a change in blood pressure was noted.A bridge occlusion balloon was immediately deployed and a pericardiocentesis was performed.The patient¿s blood pressure stabilized, the balloon was removed, a new cied system was placed and the patient was discharged to icu.No further intervention was required and the patient survived the intervention.This report will reflect on the lld as it was the traction platform used for lead removal.It is likely the effusion was caused by removal of the rv lead tip from the myocardium (as previously noted, large amount of tissue was present on lead tip).
 
Manufacturer Narrative
Corrected to indicate that the device is not being returned for manufacturing evaluation.This device was discarded.
 
Manufacturer Narrative
Follow up provided to update the device model and provide a partial udi.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRANETICS LEAD LOCKING DEVICE
Type of Device
LLD
Manufacturer (Section D)
SPECTRANETICS
9965 federal dr
colorado springs CO 80921
Manufacturer (Section G)
SPECTRANETICS
Manufacturer Contact
sondra chandler
9965 federal dr
colorado springs, CO 80921
719447-253
MDR Report Key6252061
MDR Text Key64909125
Report Number1721279-2017-00010
Device Sequence Number1
Product Code DRB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K043401
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/19/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/13/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model Number518-019
Device Catalogue Number518-019
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/03/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
MDT 4024 CARDIAC LEAD (IMPL. 1998); MDT 4524 CARDIAC LEAD (IMPL. 1998); SPECTRANETICS 13F TIGHTRAIL DILATOR SHEATH; SPECTRANETICS 14F GLIDELIGHT LASER SHEATH; SPECTRANETICS CVX-300 EXCIMER LASER; SPECTRANETICS LEAD LOCKING DEVICE
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age21 YR
Patient Weight70
-
-